Agenda - Conference Day 1 (4/11/25)

08:30 - 09:00

Registration & Coffee

09:00 - 09:10

Chair's Opening Remarks

Showing 1 of 1 Streams

Taming the Tiny Giants: Scaling Exosome Production & Purification

09:10 - 09:40

Scaling up production of extracellular vesicles – next step towards clinical therapies against Parkinson‘s disease

Augustas Pivoriunas - Co-Founder & CSO, Exosomica

09:40 - 10:10

Early identification of critical manufacturing parameters to de-risk Extracellular Vesicles production

Andreia Silva - Head of Research, Exogenus Therapeutics

10:10 - 10:40

Extracellular Vesicles: Accelerating your Path from Benchtop to IND & Beyond

Characterization: the keystone to advance EV Therapeutics
Clinical manufacturing: Highly-efficient cGMP manufacture
Xcite® EV Engineering Platform - available to license

Davide Zocco - Director, Site Management, Lonza
Marcos Langtry - Director, Commercial Development, CGT, Lonza

10:40 - 11:20

Morning Networking Break

Showing 1 of 1 Streams

Taming the Tiny Giants: Scaling Exosome Production & Purification

11:20 - 11:50

Purity at Scale: Optimizing Exosome DSP

Patrícia Pereira Müller Aguilar - Senior Scientist and Research Group Lead, acib GmbH

Showing 1 of 1 Streams

Harnessing Nature's Nanoparticles: Exosomes in Regeneration & Therapy

11:50 - 12:20

Reversible Immortalization Facilitates the Large-Scale Production of IL10-Enriched Exosomes for Osteoarthritis Therapy

Weiming Lai - Dr.Med Candidate - nstitut für Anatomie und Zellbiologie, Heidelberg University

12:20 - 12:50

Unlocking the Regenerative Power of Natural Exosomes

Tali Kizhner - RD Director, NurExone Biologic

12:50 - 13:50

Networking Lunch in Exhibit Hall

Showing 1 of 1 Streams

Harnessing Nature's Nanoparticles: Exosomes in Regeneration & Therapy

13:50 - 14:20

The Unusual Suspects: Exploring Diverse Exosome Sources

Spencer Marsh - Chief Scientific Officer, Tiny Cargo Company

Showing 1 of 1 Streams

Characterization & Ensuring Quality Manufcaturing

14:20 - 14:50

PANEL DISCUSSION: Charting the Course for Standardization: Agreeing on Exosome Quality Metrics

Key parameters for release criteria and quality control.
The role of advanced characterization (e.g., single vesicle analysis) in ensuring consistency.
- Establishing robust assays for EV products
Pathways towards community consensus on standardized methods.
- How standardisation can facilitate regulatory approval & industry evolution

Davide Zocco - Director, Site Management, Lonza
Rajeev Tawar - Associate Director, Vector and Analytical Development, Evox Therapeutics

14:50 - 15:20

Deep Dive Analytics: Characterizing Therapeutic Exosomes for Optimal Efficacy

Spotlight Presentation – Calling all Technology Thought Leaders!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

15:20 - 16:00

Afternoon Networking Break

Showing 1 of 1 Streams

Navigating the Path to Patients: Regulatory Hurdles & Early Learnings

16:00 - 16:30

Challenges in Clinical Translation for MSC Evs

Bernd Giebel - Professor for Translational Extracellular Vesicle Research at University Hospital Essen and Co-Founder & CSO, Exosla Therapeutics

16:30 - 17:00

Regulatory pathway consideration for the licensure of Exosome Therapeutics

Rion background PEP exosome product
Chemistry manufacturing and control of exosomes
Pre-clinical regulatory strategy for exosomes
Clinical trial progression of exosomes
Interacting with regulatory bodies to progress the exosome field

Dr. Maureen Merrifield - Chief Regulatory Officer, Rion Inc.

17:00 - 17:10

Chair's Closing Remarks

17:10 - 18:10

Drinks & Networking Reception

Conference Day 1 (4/11/25)Tuesday, 4 November 2025 - Amsterdam CET

Get the Latest Event Updates